Source:http://linkedlifedata.com/resource/pubmed/id/16677615
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2006-5-22
|
pubmed:abstractText |
Cyclic AMP- (cAMP) and calcium-dependent agonists stimulate chloride secretion through the coordinated activation of distinct apical and basolateral membrane channels and ion transporters in mucosal epithelial cells. Defects in the regulation of Cl- transport across mucosal surfaces occur with cystic fibrosis and V. cholerae infection and can be life threatening. Here we report that secramine B, a small molecule that inhibits activation of the Rho GTPase Cdc42, reduced cAMP-stimulated chloride secretion in the human intestinal cell line T84. Secramine B interfered with a cAMP-gated and Ba2+-sensitive K+ channel, presumably KCNQ1/KCNE3. This channel is required to maintain the membrane potential that sustains chloride secretion. In contrast, secramine B did not affect the Ca2+-mediated chloride secretion pathway, which requires a separate K+ channel activity from that of cAMP. Pirl1, another small molecule structurally unrelated to secramine B that also inhibits Cdc42 activation in vitro, similarly inhibited cAMP-dependent but not Ca2+-dependent chloride secretion. These results suggest that Rho GTPases may be involved in the regulation of the chloride secretory response and identify secramine B an inhibitor of cAMP-dependent K+ conductance in intestinal epithelial cells.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0006-2952
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
14
|
pubmed:volume |
71
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1720-6
|
pubmed:dateRevised |
2011-10-12
|
pubmed:meshHeading |
pubmed-meshheading:16677615-Benzazepines,
pubmed-meshheading:16677615-Cell Line,
pubmed-meshheading:16677615-Cyclic AMP,
pubmed-meshheading:16677615-Humans,
pubmed-meshheading:16677615-Intestinal Mucosa,
pubmed-meshheading:16677615-Ion Channel Gating,
pubmed-meshheading:16677615-Ion Transport,
pubmed-meshheading:16677615-Potassium,
pubmed-meshheading:16677615-cdc42 GTP-Binding Protein
|
pubmed:year |
2006
|
pubmed:articleTitle |
The Cdc42 inhibitor secramine B prevents cAMP-induced K+ conductance in intestinal epithelial cells.
|
pubmed:affiliation |
Department of Cell Biology and the CBR Institute for Biomedical Research, Harvard Medical School, Boston, Massachusetts, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|